Search All UT System Experts

Successful use of anti-CD20 (rituximab) in severe, life-threatening childhood immune thrombocytopenic purpura

Kristi L. Bengtson, Michael A. Skinner, Russell E. Ware

Research output: Contribution to journal › Article › peer-review

20 Scopus citations

Fingerprint

Dive into the research topics of 'Successful use of anti-CD20 (rituximab) in severe, life-threatening childhood immune thrombocytopenic purpura'. Together they form a unique fingerprint.

Medicine & Life Sciences